Company Overview and News

Sri Lankan delegation visits Vietnam for trade opportunities

2017-09-15 lankabusinessonline
Sept 15, 2017 (LBO) – A 12-member Sri Lankan delegation has visited Vietnam this month to explore trade opportunities and establish long-term connections with electronic and electrical industries.

Kelani Cables PLC annual scholarly converse ‘Kelani Knowledge Forum 2016’ enlightens electrical engineering sphere with the latest know-how yet again

Kelani Cables PLC, Sri Lanka’s number one brand in secure electrical and communication cables held its annual scholarly converse forum ‘Kelani Cables Knowledge Forum 2016’ recently at the Water’s Edge. This year’s theme was ‘Your Life and Your Business’.

Kelani Cables PLC distributes world famous Maxell batteries

Kelani Cables PLC partnered with ABC Trade & Investments (PVT) Ltd to market and distribute the world renowned consumer battery brand Maxell within the country. The official launch held at the Taj Samudra hotel, Colombo saw a MOU being signed between Mr. Mahinda Saranapala, Director/CEO, Kelani Cables PLC and Mr. Amalrajah Jayaseelan, Director/CEO, ABC Trade & Investment (Pvt) Ltd.

SL delegation explores biz opportunities in South Africa, Zambia & Rwanda

2016-04-25 lankabusinessonline
A nine member Sri Lankan business delegation, led by the Ceylon Chamber of Commerce, recently visited South Africa, Zambia and Rwanda to explore commercial opportunities in those countries.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

21h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

21h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...